Blakely CM, Urisman A, Gubens MA, Mulvey CK, et al. Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study. J Clin Oncol 2024 Jul 19:JCO2400071. doi: 10.1200/JCO.24.00071.
PMID: 39028931